Division of Biomedical Technology540
Division of Biomedical Technology aims to improve quality of human life through the convergence of basic, applied life science and biomaterial technology development. We will conduct research on disease-related mechanisms and therapeutic targets based on the companion indicators, and develop molecular and non-molecular diagnostic indicators including drug-susceptibility. Functional biomaterials and bioplastics using biocompatible polymers are under development and a variety of microplastic models are studied to test its ecological and human health hazards. We aim to contribute to the improvement of national health and quality of life as part of the national science and technology policy related to biomedical research.
DGIST Division of Biomedical Technology Homepage
DGIST Division of Biomedical Technology Homepage
Subject
- EXPRESSION 26
- PROTEIN 19
- NANOPARTICLES 17
- APOPTOSIS 16
- CELLS 16
- ACTIVATION 15
- Article 15
- GROWTH 15
- FABRICATION 14
- MODEL 12
Date issued
- 2020 - 2026 179
- 2010 - 2019 182
- 2006 - 2009 24
Co-Author(s)
Related Keyword
Recent Submissions
- Polystyrene Nanoplastics Exacerbate CCl4-Induced Liver Fibrosis by Aggravating Stretch-Induced Mechanical Stress in Hepatic Stellate Cells
- Bioreducible Cu2O cluster-glutathione nanohybrids with multienzyme-mimetic ROS scavenging for cisplatin-induced acute kidney injury
- 자성-압전 마이크로 로봇
- 자기구동시스템
- Automating population construction and parallel simulation of biophysical models for neuromuscular cells: An inverse approach
